|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1990-8-6
|
|
pubmed:abstractText |
The use of oral anticoagulation in the long-term treatment of survivors of acute myocardial infarction has been highly controversial. We therefore randomly assigned 1214 patients who had recovered from acute myocardial infarction (mean interval from the onset of symptoms to randomization, 27 days) to treatment with warfarin (607 patients) or placebo (607 patients) for an average of 37 months (range, 24 to 63).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
323
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-52
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:2194126-Cerebrovascular Disorders,
pubmed-meshheading:2194126-Female,
pubmed-meshheading:2194126-Hemorrhage,
pubmed-meshheading:2194126-Humans,
pubmed-meshheading:2194126-Male,
pubmed-meshheading:2194126-Middle Aged,
pubmed-meshheading:2194126-Myocardial Infarction,
pubmed-meshheading:2194126-Randomized Controlled Trials as Topic,
pubmed-meshheading:2194126-Recurrence,
pubmed-meshheading:2194126-Thromboembolism,
pubmed-meshheading:2194126-Warfarin
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
The effect of warfarin on mortality and reinfarction after myocardial infarction.
|
|
pubmed:affiliation |
Department of Medicine, Red Cross Clinic, Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
